Gradient Investments LLC - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 26 filers reported holding TENAX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Gradient Investments LLC ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$010.0%0.00%
Q1 2019$010.0%0.00%
Q4 2018$010.0%0.00%
Q3 2018$010.0%0.00%
Q2 2018$010.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,019,995$3,838,0000.09%
FAS Wealth Partners, Inc. 58,326$111,0000.01%
Renaissance Technologies 747,832$1,421,0000.00%
Valeo Financial Advisors, LLC 5,000$10,0000.00%
Gradient Investments LLC 1$00.00%
Hudock, Inc. 1$00.00%
Allworth Financial LP 1$00.00%
DIMENSIONAL FUND ADVISORS LP 60,412$115,0000.00%
BANK OF AMERICA CORP /DE/ 100$00.00%
WELLS FARGO & COMPANY/MN 96$00.00%
View complete list of TENAX THERAPEUTICS INC shareholders